A bipartisan group of U.S. Senators is expected to hold a meeting to discuss unresolved issues related to the Clarity Act.
BlockBeats news, June 18 — With just over a week until the US Senate recesses on July 4, crypto-supporting senators and government officials are continuing behind-the-scenes negotiations to bring the Clarity Act to a floor vote when lawmakers return. According to sources, a bipartisan group of senators from the Senate Banking Committee and Agriculture Committee is expected to meet this morning to discuss outstanding issues.
Later today, acting Attorney General Todd Blanche will meet with law enforcement agencies as the government continues efforts to secure broad support for a key but controversial provision of the Blockchain Regulatory Certainty Act. This measure would clarify that certain non-custodial software developers are not liable for how third parties use their code, unless they knowingly and intentionally facilitate illegal activity through their code. (Crypto In America)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Crypto prices
More
